GlassScriptPhysician profile
James C Beckman
NPI 1730102278
$4,132.90
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,434 · 2020: $1,456 · 2021: $884 · 2022: $359.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $572.95 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $403.15 | 2019-2021 | |
| Novo Nordisk INC | $382.71 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $366.88 | 2019-2022 | |
| Amarin Pharma, INC. | $337.30 | 2019-2021 | |
| Lilly USA, LLC | $231.26 | 2019-2021 | |
| Pfizer INC. | $229.92 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.53 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $177.36 | 2019-2022 | |
| Abbvie INC. | $165.40 | 2019-2022 | |
| Allergan, INC. | $140.15 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $97.05 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $96.68 | 2020-2021 | |
| Eisai INC. | $84.83 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.36 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $74.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $73.36 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $71.68 | 2019-2021 | |
| Glaxosmithkline, LLC. | $69.23 | 2019-2022 | |
| Esperion Therapeutics, INC. | $45.27 | 2021-2022 | |
| Antares Pharma, INC. | $44.53 | 2019 | |
| Radius Health, INC. | $38.43 | 2019-2020 | |
| Bausch Health US, LLC | $29.28 | 2019-2022 | |
| Astellas Pharma US INC | $26.10 | 2020 | |
| Abbott Laboratories | $23.51 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.84 | 2022 | |
| Sanofi Pasteur INC. | $21.94 | 2022 | |
| Valeritas, INC. | $16.92 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.89 | 2021 | |
| Horizon Therapeutics Plc | $12.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Beckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.